127 related articles for article (PubMed ID: 38161125)
21. NT-proBNP level in stage 3-4 chronic kidney disease and mortality in long-term follow-up: HAPPY study subgroup analysis.
Şimşek MA; Değertekin M; Türer Cabbar A; Hünük B; Aktürk S; Erdoğmuş S; Mutlu B; Kozan Ö
Turk Kardiyol Dern Ars; 2020 Jul; 48(5):454-460. PubMed ID: 32633264
[TBL] [Abstract][Full Text] [Related]
22. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.
Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H
ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of Elevated NT-proBNP and its Prognostic Value by Blood Pressure Treatment and Control.
Daya NR; McEvoy JW; Christenson RH; Tang O; Foti K; Juraschek SP; Selvin E; Echouffo-Tcheugui JB
Am J Hypertens; 2023 Oct; 36(11):602-611. PubMed ID: 37458697
[TBL] [Abstract][Full Text] [Related]
25. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
26. B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias.
Levine YC; Rosenberg MA; Mittleman M; Samuel M; Methachittiphan N; Link M; Josephson ME; Buxton AE
Heart Rhythm; 2014 Jul; 11(7):1109-16. PubMed ID: 24837348
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.
Chen X; Wu M; Xu K; Huang M; Zhuo X
Acta Cardiol; 2021 Feb; 76(1):87-92. PubMed ID: 32519930
[TBL] [Abstract][Full Text] [Related]
28. Myocardial fibrosis combined with NT-proBNP improves the accuracy of survival prediction in ADHF patients.
Yao Y; Feng L; Sun Y; Wang S; Sun J; Hu B
BMC Cardiovasc Disord; 2021 May; 21(1):264. PubMed ID: 34049488
[TBL] [Abstract][Full Text] [Related]
29. Association of NT-proBNP and BNP With Future Clinical Outcomes in Patients With ESKD: A Systematic Review and Meta-analysis.
Harrison TG; Shukalek CB; Hemmelgarn BR; Zarnke KB; Ronksley PE; Iragorri N; Graham MM; James MT
Am J Kidney Dis; 2020 Aug; 76(2):233-247. PubMed ID: 32387090
[TBL] [Abstract][Full Text] [Related]
30. N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID-19 in a Nationwide Hospitalized Cohort.
O'Donnell C; Ashland MD; Vasti EC; Lu Y; Chang AY; Wang P; Daniels LB; de Lemos JA; Morrow DA; Rodriguez F; O'Brien CG
J Am Heart Assoc; 2021 Dec; 10(24):e022913. PubMed ID: 34889112
[TBL] [Abstract][Full Text] [Related]
31. Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohort.
Gingo MR; Zhang Y; Ghebrehawariat KB; Jeong JH; Chu Y; Yang Q; Lucht L; Hanna DB; Lazar JM; Gladwin MT; Morris A
PLoS One; 2015; 10(3):e0123389. PubMed ID: 25811188
[TBL] [Abstract][Full Text] [Related]
32. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
Bai J; Han L; Liu H
Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
[TBL] [Abstract][Full Text] [Related]
33. Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.
Tan ESJ; Chan SP; Liew OW; Chong JPC; Gerard Leong KT; Daniel Yeo PS; Ong HY; Jaufeerally F; Sim D; Ling LH; Lam CSP; Richards AM
JACC Heart Fail; 2024 Mar; 12(3):461-474. PubMed ID: 37897459
[TBL] [Abstract][Full Text] [Related]
34. N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study.
Ezekowitz JA; O'Connor CM; Troughton RW; Alemayehu WG; Westerhout CM; Voors AA; Butler J; Lam CSP; Ponikowski P; Emdin M; Patel MJ; Pieske B; Roessig L; Hernandez AF; Armstrong PW
JACC Heart Fail; 2020 Nov; 8(11):931-939. PubMed ID: 33039447
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
[TBL] [Abstract][Full Text] [Related]
36. [Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].
Li YY; Liang YD; Yao SM; Zheng PP; Zeng XZ; Cui LL; Guo D; Wang H; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):661-668. PubMed ID: 32847322
[No Abstract] [Full Text] [Related]
37. Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients.
Molvin J; Jujic A; Bachus E; Gallo W; Tasevska-Dinevska G; Holm H; Melander O; Fedorowski A; Magnusson M
ESC Heart Fail; 2019 Oct; 6(5):992-999. PubMed ID: 31339668
[TBL] [Abstract][Full Text] [Related]
38. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death.
Jia X; Al Rifai M; Hoogeveen R; Echouffo-Tcheugui JB; Shah AM; Ndumele CE; Virani SS; Bozkurt B; Selvin E; Ballantyne CM; Nambi V
JAMA Cardiol; 2023 Mar; 8(3):222-230. PubMed ID: 36753229
[TBL] [Abstract][Full Text] [Related]
39. The potential role of NT-proBNP in screening for and predicting prognosis in heart failure: a survival analysis.
Taylor CJ; Roalfe AK; Iles R; Hobbs FD
BMJ Open; 2014 Apr; 4(4):e004675. PubMed ID: 24747793
[TBL] [Abstract][Full Text] [Related]
40. [Predictive value of plasma TMAO combined with NT-proBNP on the prognosis and length of hospitalization of patients with ischemic heart failure].
Qiu WD; Xiao XJ; Xia S; Gao ZP; Li LW
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):684-689. PubMed ID: 35856225
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
